Searched for
SUN HALOL PLANT
Organon gives Sun Pharma scale and reach, but challenge lies in integration, executionSun Pharma has acquired Organon & Co for $11.75 billion. This deal provides Sun Pharma with expanded global scale and commercial reach. It ...- Can Sun Pharma's quarterly show reinforce investor confidence in stock?The company intends to increase its specialty drug portfolio in its core areas of dermatology and ophthalmology. This comes at a time when ...
- USFDA pulls up Sun Pharma for lapses in Halol plant"This warning letter summarises significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceutica...
- USFDA conducting inspection of Mohali plant: Sun PharmaThe inspection by the United States Food and Drug Administration (USFDA) started on September 10, 2018 and is ongoing, Sun Pharma said in a...
- Sun Pharma slips 4% on USFDA observationsSun Pharma has reported a consolidated net profit of Rs 982.51 crore for the June quarter.
- USFDA subjects SPARC Xelpros nod to 'satisfactory resolution'Earlier this month, Sun Pharma said the US health regulator had made nine observations after the completion of inspection of its Halol faci...
- USFDA report on Halol unit to be positive in long-term: SunThe company's Halol facility recently underwent an inspection by the US Food and Drug Administration (USFDA).
- Sun Pharma EPS may fall by up to 6% on USFDA notice on Halol plantThe US FDA issued the notice on Tuesday with nine inspectional observations after an onsite inspection of Sun Pharma’s Halol facility in Gu...
- The jewel of the Indian pharma crown has lost its shine: Amit Ranjan on Sun PharmaSun Pharma got two inspections – one for Mohali and one for Halol sight – and if you summarise, I am sorry to say that the jewel of the Ind...
- US FDA finds fault in accuracy of test methods at Sun’s Halol siteThe agency also found that scientifically sound and appropriate lab control mechanisms were not established.
- USFDA made 9 observations post Halol unit inspection: Sun PharmaThe United States Food and Drug Administration (USFDA) inspected the Halol facility from November 17, 2016 through December 1, 2016, Sun Ph...
- FDA issues observations post Sun Pharma Halol plant inspectionThe approval of several of Sun's key drugs in the United States, the drugmaker's biggest market, depends on the clearance on its Halol plan...
- Sun Pharma shares set to extend losses for fourth day on rising concern over Halol facilityETNow on Tuesday reported that the USFDA has informed that the Halol facility has issued a 14-page Form 483 post inspection.
- For Sun Pharma, a lot rides on USFDA's report on Halol PlantThe Sun Pharma stock has appreciated 13% since the announcement of its second quarter performance on November 10.
- Sun Pharma rises 2% as USFDA issues 7 observations on Mohali sitePrabhudas Lilladher said the current price still does not reflect key positives like Ranbaxy integration benefits, Halol plant resolution a...
- Sun Pharma's problems to continue for another 2-3 quartersThe company's Halol plant has been under the scanner of US Food and Drug Administration (USFDA) for alleged violations of good manufacturin...
- Sun Pharma to ask FDA in Q1 FY17 for Halol re-inspectionDrug major Sun Pharmaceutical Industries may ask the US health regulator in the first quarter of next fiscal for re-inspection of its Halol...
- Sun Pharma shares a good buy despite short-term painStock may see a sell-off on earnings downgrades & FDA warning, but co has not revised revenue guidance & FIs have steadily raised holdings.
- Sun Pharma gains 2%; BofA ML sets target at Rs 1,070BofA-ML said, "The potential upside for the stock could be over 40 per cent if the Halol issue does not escalate."
- Focus on getting Ranbaxy's plants USFDA nod one at a time: Sun PharmaSun Pharma, which acquired Ranbaxy in a $4 bn deal, feels it is important for the merged entity to "re-establish" the trust between Ranbaxy...
Load More
